These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9844784)

  • 1. Soluble CD44-isoform variant-5 (sCD44v5) in psoriatic arthritis.
    Haberhauer G; Kittl EM; Bauer K; Skoumal M; Feyertag J; Dunky A
    Clin Exp Rheumatol; 1998; 16(6):766-7. PubMed ID: 9844784
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CD44 isoform variant-5 (sCD44v5): a new serum marker in rheumatoid arthritis?
    Haberhauer G; Kittl EM
    J Rheumatol; 1998 Jul; 25(7):1442-4. PubMed ID: 9676786
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A].
    Feyertag J; Haberhauer G; Skoumal M; Kittl EM; Bauer K; Dunky A
    Acta Med Austriaca; 2000; 27(5):156-9. PubMed ID: 11261266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis.
    Kittl EM; Haberhauer G; Ruckser R; Selleny S; Rech-Weichselbraun I; Hinterberger W; Bauer K
    Rheumatol Int; 1997; 16(5):181-6. PubMed ID: 9032816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis.
    Haberhauer G; Kittl EM; Skoumal M; Hübl W; Wagner E; Bayer PM; Bauer K; Dunky A
    Acta Med Austriaca; 1997; 24(1):23-5. PubMed ID: 9150806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
    Holzer G; Kittl E; Pfandelsteiner T; Trieb K; Kotz R
    Med Pediatr Oncol; 2003 Jan; 40(1):64-5. PubMed ID: 12426692
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased serum TWEAK levels in Psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels.
    Xia L; Shen H; Xiao W; Lu J
    Cytokine; 2011 Mar; 53(3):289-91. PubMed ID: 21190865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients.
    Kittl EM; Ruckser R; Selleny S; Samek V; Hofmann J; Huber K; Reiner A; Ogris E; Hinterberger W; Bauer K
    Exp Clin Immunogenet; 1997; 14(4):264-72. PubMed ID: 9523162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis.
    Chandran V; Cook RJ; Edwin J; Shen H; Pellett FJ; Shanmugarajah S; Rosen CF; Gladman DD
    Rheumatology (Oxford); 2010 Jul; 49(7):1399-405. PubMed ID: 20421218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis.
    Tsai YG; Chang DM; Kuo SY; Wang WM; Chen YC; Lai JH
    J Microbiol Immunol Infect; 2003 Jun; 36(2):101-4. PubMed ID: 12886960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A.
    Saso L; Valentini G; Giardino AM; Spadaro A; Riccieri V; Zoppini A; Silvestrini B
    Biochem Mol Biol Int; 1998 Dec; 46(5):867-75. PubMed ID: 9861440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal distribution of hyaluronan in psoriatic arthritis; coexistence of CD44, MMP3 and MMP9.
    Lindqvist U; Phil-Lundin I; Engström-Laurent A
    Acta Derm Venereol; 2012 Jul; 92(4):372-7. PubMed ID: 22278305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Clin Exp Rheumatol; 1996; 14(4):413-6. PubMed ID: 8871841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic levels of soluble CD44 variant 6 (sCD44v6) in chronic inflammatory bowel disease.
    Folwaczny C; Noehl N; Urban S; Loeschke K; Heldwein W; Jochum M; Fricke H
    Am J Gastroenterol; 1996 Aug; 91(8):1680-1. PubMed ID: 8759709
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone turnover markers evaluation in psoriatic arthritis].
    Ciacli C; Puşchiţă M; Drugărin D; Solovan C; Gurban CV; Cotoraci C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):635-40. PubMed ID: 20201244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of reputed tumor-associated soluble CD44 isoforms (v5 and v6) in smokers are dose related and decline on smoking cessation.
    Scott DA; Stapleton JA; Palmer RM; Wilson RF; Sutherland G; Coward PY; Gustavsson G; Odell EW; Poston RN
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1211-4. PubMed ID: 11097229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.